Cetilistat

Cetilistat
  • CAS No.:282526-98-1
Other grades of this product :
Cetilistat Basic information
Product Name:Cetilistat
Synonyms:cetilistat;Cetilistat(Alt-962);Cetilstat;2-(Hexadecyloxy)-6-methyl-4H-3,1-benzoxazin-4-one;2-(Hexadecycloxy)-6-methyl-4H-3,1-benzoxazin-4-one;New alistat;2-hexadecoxy-6-methyl-3,1-benzoxazin-4-one;Cetilistat (ATL-962)
CAS:282526-98-1
MF:C25H39NO3
MW:401.58
EINECS:1308068-626-2
Product Categories:Cetilistat;Other series;Aromatics;Heterocycles;Inhibitors;API;Intermediates & Fine Chemicals;Pharmaceuticals;BDO;282526-98-1
Mol File:282526-98-1.mol
Cetilistat Chemical Properties
Melting point 72.0 to 76.0 °C
Boiling point 509.7±43.0 °C(Predicted)
density 1.02
storage temp. 2-8°C
solubility Chloroform (Slightly), Ethyl Acetate (Slightly)
form Solid
pka2.96±0.20(Predicted)
color White to Off-White
InChIKeyMVCQKIKWYUURMU-UHFFFAOYSA-N
CAS DataBase Reference282526-98-1(CAS DataBase Reference)
Safety Information
MSDS Information
Cetilistat Usage And Synthesis
DescriptionCetilistat (also known as ATL-962) was approved in September 2013 by the Japanese Ministry of Health, Labor and Welfare for the treatment of obesity, limited to patients with both type 2 diabetes mellitus (T2DM) and dyslipidemia, and with a body mass index (BMI)25 kg/m2 in spite of dietary treatment and/or exercise therapy. As with orlistat, cetilistat works via inhibition of pancreatic lipases in the gut to inhibit fat absorption and thereby reduce caloric uptake from diet. The medicinal chemistry program has not been described in the scientific literature, but the patent describing cetilistat also describes the synthesis of analogs with varied aryl substituents and lipophilic tails. The synthesis of cetilistat involves condensation of a hexadecylcarbonochloridate with 2-amino-5-methylbenzoic acid; other analogs were synthesized by varying the carbonochloridate and 2-aminobenzoic acid components. Cetilistat is a potent inhibitor of human and rat pancreatic lipase with IC50s of 15 and 136 nM, respectively, with little inhibition of trypsin or chymotrypsin.
Chemical PropertiesOff-white Cryst
OriginatorAlizyme PLC (United Kingdom)
UsesA novel pancreatic lipase inhibitor for the treatment of obesity in both diabetic and non-diabetic patients.
Brand nameOblean
SynthesisCommercially available hexadecanol (21) was treated with phosgene in THF/toluene to give the corresponding chloroformate (22), which was immediately subjected to commercial 2-amino-5- methylbenzoic acid (23) in pyridine. Subsequent slow addition of methyl chloroformate at room temperature resulted in the formation of cetilistat (IV), which was produced in 31% overall yield from hexadecanol.
Cetilistat Preparation Products And Raw materials

Welcome!

Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.

  • NO. 18 ,Wujiang Road, Wulidian Street, Jiangbei District, Chongqing
  • +86-23-6139-8061 +86-13650506873
  • danny@chemdad.com sales@chemdad.com
  • www.chemdad.com
  • WhatsApp +86-13650506873

Name

phone

company

email

message

Payment methods
Google translate: 日本语日本语 한국어한국어 FrançaisFrançais DeutschDeutsch EspañaEspaña TürkiyeTürkiye